Journey Medical (DERM) Competitors

Journey Medical (NASDAQ:DERM) and Sana Biotechnology (NASDAQ:SANA) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their risk, institutional ownership, analyst recommendations, media sentiment, earnings, dividends, valuation, community ranking and profitability.

Which has more volatility & risk, DERM or SANA?

Journey Medical has a beta of 0.97, meaning that its stock price is 3% less volatile than the S&P 500. Comparatively, Sana Biotechnology has a beta of 1.63, meaning that its stock price is 63% more volatile than the S&P 500.

Do insiders and institutionals have more ownership in DERM or SANA?

7.3% of Journey Medical shares are held by institutional investors. Comparatively, 88.2% of Sana Biotechnology shares are held by institutional investors. 13.2% of Journey Medical shares are held by insiders. Comparatively, 31.1% of Sana Biotechnology shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Does the MarketBeat Community believe in DERM or SANA?

Sana Biotechnology received 17 more outperform votes than Journey Medical when rated by MarketBeat users. However, 100.00% of users gave Journey Medical an outperform vote while only 63.89% of users gave Sana Biotechnology an outperform vote.

Company	Underperform	Outperform
Journey Medical	Outperform Votes 6 100.00%	Underperform Votes No Votes
Sana Biotechnology	Outperform Votes 23 63.89%	Underperform Votes 13 36.11%

Does the media prefer DERM or SANA?

In the previous week, Sana Biotechnology had 16 more articles in the media than Journey Medical. MarketBeat recorded 24 mentions for Sana Biotechnology and 8 mentions for Journey Medical. Journey Medical's average media sentiment score of 0.64 beat Sana Biotechnology's score of 0.18 indicating that Journey Medical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Journey Medical	1 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Sana Biotechnology	1 Very Positive mention(s)	3 Positive mention(s)	18 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Do analysts rate DERM or SANA?

Journey Medical presently has a consensus target price of $9.67, indicating a potential upside of 63.29%. Sana Biotechnology has a consensus target price of $10.80, indicating a potential upside of 485.37%. Given Sana Biotechnology's higher probable upside, analysts clearly believe Sana Biotechnology is more favorable than Journey Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Journey Medical	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	3.25
Sana Biotechnology	0 Sell rating(s)	1 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.86

Is DERM or SANA more profitable?

Sana Biotechnology has a net margin of 0.00% compared to Journey Medical's net margin of -31.74%. Sana Biotechnology's return on equity of -84.22% beat Journey Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Journey Medical	-31.74%	-132.10%	-26.90%
Sana Biotechnology	N/A	-84.22%	-44.97%

Which has higher valuation and earnings, DERM or SANA?

Journey Medical has higher revenue and earnings than Sana Biotechnology. Journey Medical is trading at a lower price-to-earnings ratio than Sana Biotechnology, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Journey Medical	$57.77M	2.14	-$3.85M	-$0.94	-6.30
Sana Biotechnology	N/A	N/A	-$283.26M	-$1.16	-1.59

Summary

Sana Biotechnology beats Journey Medical on 10 of the 18 factors compared between the two stocks.